Edgewise Therapeutics Grants Stock Options to New Employee Under Inducement Plan
I'm PortAI, I can summarize articles.
Edgewise Therapeutics Inc. has granted stock options to a new non-executive employee under its 2024 Inducement Equity Incentive Plan. The employee can purchase 26,250 shares at $26.04 per share, with vesting over four years. This announcement was made via PR Newswire and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments